Middle East and Africa Wound Care Market Size, Share & Industry Analysis, By Type (Advanced Wound Dressings, {Antimicrobial Dressings, Alginate Dressings, Foam Dressings, and Others}, Traditional Wound Care Products, Negative Pressure Wound Therapy, Bioactives {Biological Skin Equivalents, Growth Factors, and Others}, and Others), By Application (Chronic Wounds {Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others} and Acute Wounds {Surgical Wounds and Burns}), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Regional Forecast, 2023-2030

Middle East and Africa wound care market size is expected to grow at a considerable rate in the coming years. It is projected to record a CAGR of 4.6% during the forecast period. The global market is projected to grow from USD 18.51 billion in 2022 to USD 30.04 billion by 2030.

The increasing number of people suffering from chronic disorders and growing burden of the geriatric population in the region are anticipated to drive the market’s growth. Many research studies have reported that chronic disorders, such as diabetes are more prevalent among the elderly population, ultimately increasing the risk of developing diabetes-associated complications, such as diabetic foot ulcers.

• According to the International Diabetes Federation’s 2021 report, an estimated 73 million adults were suffering from diabetes in the Middle East and North Africa region. This number is projected to increase to 95 million by 2030.

This report on the Middle East and Africa wound care market covers the following countries/regions – South Africa, GCC, and the Rest of the Middle East and Africa.

LATEST TRENDS

Rising Research to Develop Bioactive Wound Care Products to Aid Market Growth

The shifting preference among the population toward advanced wound care products with improved efficiency and healing properties has bolstered investments in research and development across the region to develop technologically advanced products and cater to the rising demand. Furthermore, regulatory bodies in the region are approving these products to improve wound management and lower the burden of wound care. These factors are likely to have lucrative opportunities for the Middle East and Africa wound care market growth.

For instance, according to a press release published by the Times of Oman in January 2022, scientists from the University of Nizwa, Oman developed a revolutionary bioactive wound dressing based on chitosan and alginate. The dressing claimed to improve the healing time of wounds by many folds.

DRIVING FACTORS

Rising Burden of Chronic Wounds to Raise Demand for Wound Care Products

This market is anticipated to witness lucrative growth due to increasing burden of the geriatric population in the region. Prevalence of chronic wounds, such as pressure ulcers is common among the old-age population. Furthermore, patients suffering from spinal cord injuries and bedridden are more prone to develop pressure ulcers, thereby raising the demand for these products.

According to a research study published in NCBI in 2020, the prevalence of pressure ulcers in Africa was around 11% in general hospital units. This prevalence increased to 44% in spinal injury units.

RESTRAINING FACTORS

Lack of Awareness Regarding Wound Management to Impede Market Growth

Despite the integration of latest technologies in wound care products, the adoption of these products is likely to be low in the region due to lack of proper awareness among the population.

• For instance, according to a study published in NCBI in 2020, out of 414 participants in Riyadh, Saudi Arabia, approximately 73% of them used home remedies, such as petroleum jelly, butter, coffee beans, and toothpaste, on their wounds.

Thus, gaps in knowledge and beliefs among the population and lack of awareness are anticipated to limit the adoption of wound care products.

KEY INDUSTRY PLAYERS

The market in the region is semi-consolidated, with a few key players, such as Smith & Nephew, Mölnlycke Health Care AB, and ConvaTec Group PLC leading the market. Currently, companies operating in this market are shifting their focus to expand their presence in the Middle East and Africa by launching various novel products. Moreover, these companies are establishing distribution partnerships with local distributors to increase their geographical reach. Thus, the market is expected to grow owing to an increase in such initiatives.

• For instance, in June 2022, Mölnlycke Health Care AB launched Avance Solo, a Negative Pressure Wound Therapy (NPWT) system device in the Middle East.

LIST OF KEY COMPANIES PROFILED:

• Coloplast A/S (Denmark)


• Paul Hartmann AG (Germany)


• Smith & Nephew (U.K.)


• ConvaTec Group PLC (U.K.)


• Mölnlycke Health Care AB (Sweden)


• B. Braun Melsungen AG (Germany)


• Medtronic (Ireland)


• Integra Lifesciences (U.S.)


• 3M (U.S.)


• Integra Lifesciences corporation (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• November 2022: Magle Group received regulatory approval from Kuwait for its AXXO Woundgel to treat and prevent wound infection.


• May 2022: RLS Global, an advanced wound care company, strengthened its presence in the Middle East by partnering with regional company Medsurg for the distribution of ChloraSolv in Egypt, Saudi Arabia, Iraq, Lebanon, Qatar, the United Arab Emirates, Oman, and Jordan after its approval.

REPORT COVERAGE

The market research report provides qualitative and quantitative insights on the market and a detailed analysis of the regional market’s size & growth rate for all possible segments in the market. Along with the market forecast, the report provides an elaborative analysis of the market dynamics, Middle East and Africa wound care market share of key companies, and competitive landscape. Various key insights presented in the report are an overview of the prevalence of various chronic diseases in the region, new product launches, key industry developments – mergers, acquisitions & partnerships, and the impact of COVID-19 on the market.

Report Scope & Segmentation